Home Industries Market Insights About Us Publisher Contact us

Biobanking Market By Specimen Type (Blood Products, Cell Lines, Solid Tissue, Nucleic Acid, Biological Fluids, Human Waste Products), Biobank Type (Population-based Biobank, Disease-oriented Biobank), Application (Regenerative Medicine, Clinical Research, Life Science Research) - Global Opportunity Analysis And Industry Forecast, 2021-2027

Categories: Life Science

Formate :

Global Biobanking Market Overview

The Global Biobanking Market Size, Share, and Trends are estimated to reach $60,596 million by 2026, growing at a CAGR of 6.3% over the forecast period of 2021-2026. Biobank collects biological samples and associated information for research and development purposes and is organized systematically. As a result, Biobanking is becoming an essential resource in healthcare research for supporting contemporary research, such as personalized medicine and genomics. 

 

Biobanks in most developed nations were established as local units to support specific research projects. Moreover, Modern biobanks worldwide permit large-scale analysis with well-annotated biological and clinical data. Major growth factors of the Biobanking market include growing funding from government organizations, rise in the application areas of biobanking samples, and increasing investment in research and development activities by healthcare companies across the world.

 

Key Takeaways from Global Biobanking Market Report:

  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level – for specimen types, biobank types, and by different industry verticals.
  • Understand the market dynamics – key driving factors, challenges, and hidden opportunities.
  • Get in-depth insights on your competitor's performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT, and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep dive on the value augmentation at each step to optimize value and bring efficiencies in your processes.
  • Get a quick outlook on the market entropy – M&As, deals, partnerships, product launches of all key players for the past four years.
  • Evaluate the supply-demand gaps, import-export statistics, and regulatory landscape for more than the top 20 countries globally for the market.

 

By Specimen type, the market for solid tissue to grow at the highest CAGR during the forecast period

During the forecast period, the market for solid tissue is predicted to develop at the fastest rate of XX%. Quality fresh solid tissues are critical for molecular -diagnostics and translational cancer research. Therefore, solid-tissue samples are primarily collected in hospitals for urgent procedures. In addition, the growing prevalence of neurological and cardiovascular disorders and the demand for regenerative medicines are propelling solid tissues.

 

Biobank Type's Biobanking market for Disease-oriented Biobank to grow at the highest CAGR during the forecast period.

The Biobanking Industry for Disease-oriented Biobank is predicted to develop at the fastest CAGR during the projection period. Disease-oriented biobanks across the globe store more heterogeneous collections of biological materials. Disease-oriented biobanks focus on single tissue types, such as brain, and multiple tissue types, such as pancreatic, breast, liver, and colon specimens held in a cancer biobank. In addition, most of the Disease-oriented biobanks have affiliations with hospitals for collecting samples representing a variety of diseases, which is driving the Biobanking market growth.

 

North America to account for the largest market share during the forecast period.

North America held the largest share of the Biobanking market in 2020, with a global market share of 35.3%. The demand for Biobanking in North America is growing owing to the increasing number of research and development activities in genomics, the growing availability of hospital-based biobanks, and the demand for cost-effective drug development. Furthermore, the rise in the need for various treatment options for several chronic diseases owing to the availability of technologically advanced devices is propelling the demand for Biobanking in the region.

 

The Asia Pacific is set to be the fastest-growing over 2021-2026. The major drivers for the rapid growth of the Biobanking market in the Asia Pacific are the growing awareness about biobanks, increasing focus on early diagnosis of various diseases, and the rise in the adoption of disease-oriented Biobanks for research activities in the region.

 

Market Dynamics

Driver:  

Growing demand for Biobanking for regenerative medicine applications.

Biobanking effectively plays a role in advancing translational and biomedical research by preserving and collecting samples, such as nucleic acids and blood tissues that are available for discovering disease-relevant biomarkers. In addition, technological advancements in orthopedic treatments with stem cells are propelling the demand for regenerative medicines worldwide. 

 

Moreover, the growing focus by the government on funding is supporting the research activities on regenerative medicines. Regenerative medicine and tissue engineering are increasingly playing significant roles in treating intractable conditions, such as chronic osteoarthritis, chronic heart failure, stroke, and other disorders, propelling the demand for Biobanking. Researchers in developed nations are focusing on stem cell banking, such as cord blood, bone marrow, adipose tissue methodology, to enhance the utilization of stem cells in pre-clinical and clinical trials and animal models.

 

Challenge: 

Long-term financial sustainability of biobanks.

Long-term financial sustainability is one of the significant challenges faced by the biobanks. Many managers and researchers worldwide cited economic sustainability as the foremost hurdle to ensure the long-term stability of biobanks. Funding of biobanks involves many streams, such as commercialization of derived products, cost recovery related to samples, financing from private entities, and funding through governmental agencies and institutions. However, long-term sustainability requires more than just covering the marginal costs. During the projected period, the impact of this difficulty is predicted to be moderate.

 

Competitive Landscape

Key Players in the Global Biobanking Market are listed below: 

  • Thermo Fisher Scientific Inc (US)
  • Qiagen N.V. (Germany)
  • Tecan Group Ltd (Switzerland)
  • Brooks Automation (US)
  • Hamilton Company (US)
  • VWR Corporation (US)
  • Worthington Industries (US)
  • Becton
  • Dickinson and Company (US)
  • LVL Technologies (Germany)
  • Panasonic Healthcare Holdings (Japan) 

 

Recent Developments:

  • In May 2017, Brooks Automation launched BioStudies™ Biobank Data Management System from MicroStrategy with Built-in Visualization Capabilities to provide the most comprehensive purpose-built intelligence software system to optimize biological samples sharing biobank sample data.

 

Report Coverage and Scope

The report "Global Biobanking Market" by Research Informatic covers an in-depth detailed analysis for the following segment covered under the scope.

 

By Specimen Type

  • Blood Products
  • Cell Lines
  • Solid Tissue
  • Nucleic Acid
  • Biological Fluids
  • Human Waste Products

 

By Biobank Type

  • Population-based Biobank
  • Disease-oriented Biobank

 

By Application

  • Regenerative Medicine
  • Clinical Research
  • Life Science Research

 

Geography

  • North America
  • Europe
  • APAC
  • RoW

 

 


 


Chapter 1 Biobanking Market Overview


1.1 Product Overview and Scope of Biobanking


1.2 Biobanking Market Segmentation By Specimen Type


1.2.1 Blood Products


1.2.2 Cell Lines


1.2.3 Solid Tissue


1.2.4 Nucleic Acid


1.2.5 Biological Fluids


1.2.6 Human Waste Products


1.3 Biobanking Market Segmentation by Application


1.3.1 Regenerative Medicine


1.3.2 Clinical Research


1.3.3 Life Science Research


1.4 Biobanking Market Segmentation by Regions


1.4.1 North America


1.4.2 China


1.4.3 Europe


1.4.4 Southeast Asia


1.4.5 Japan


1.4.6 India


1.5 Global Market Size (Value) of Biobanking (2015-2027)


 


Chapter 2 Global Economic Impact on Biobanking Industry


2.1 Global Macroeconomic Environment Analysis


2.1.1 Global Macroeconomic Analysis


2.1.2 Global Macroeconomic Environment Development Trend


2.2 Global Macroeconomic Environment Analysis by Regions


 


Chapter 3 Global Biobanking Market Competition by Manufacturers


3.1 Global Biobanking Production and Share by Manufacturers (2021 and 2021)


3.2 Global Biobanking Revenue and Share by Manufacturers (2021 and 2021)


3.3 Global Biobanking Average Price by Manufacturers (2021 and 2021)


3.4 Manufacturers Biobanking Manufacturing Base Distribution, Production Area and Product Type


3.5 Biobanking Market Competitive Situation and Trends


3.5.1 Biobanking Market Concentration Rate


3.5.2 Biobanking Market Share of Top 3 and Top 5 Manufacturers


3.5.3 Mergers & Acquisitions, Expansion


 


Chapter 4 Global Biobanking Production, Revenue (Value) by Region (2015-2021)


4.1 Global Biobanking Production by Region (2015-2021)


4.2 Global Biobanking Production Market Share by Region (2015-2021)


4.3 Global Biobanking Revenue (Value) and Market Share by Region (2015-2021)


4.4 Global Biobanking Production, Revenue, Price and Gross Margin (2015-2021)


4.5 North America Biobanking Production, Revenue, Price and Gross Margin (2015-2021)


4.6 Europe Biobanking Production, Revenue, Price and Gross Margin (2015-2021)


4.7 China Biobanking Production, Revenue, Price and Gross Margin (2015-2021)


4.8 Japan Biobanking Production, Revenue, Price and Gross Margin (2015-2021)


4.9 Southeast Asia Biobanking Production, Revenue, Price and Gross Margin (2015-2021)


4.10 India Biobanking Production, Revenue, Price and Gross Margin (2015-2021)


 


Chapter 5 Global Biobanking Supply (Production), Consumption, Export, Import by Regions (2015-2021)


5.1 Global Biobanking Consumption by Regions (2015-2021)


5.2 North America Biobanking Production, Consumption, Export, Import by Regions (2015-2021)


5.3 Europe Biobanking Production, Consumption, Export, Import by Regions (2015-2021)


5.4 China Biobanking Production, Consumption, Export, Import by Regions (2015-2021)


5.5 Japan Biobanking Production, Consumption, Export, Import by Regions (2015-2021)


5.6 Southeast Asia Biobanking Production, Consumption, Export, Import by Regions (2015-2021)


5.7 India Biobanking Production, Consumption, Export, Import by Regions (2015-2021)


 


Chapter 6 Global Biobanking Production, Revenue (Value), Price Trend by Type


6.1 Global Biobanking Production and Market Share by Type (2015-2021)


6.2 Global Biobanking Revenue and Market Share by Type (2015-2021)


6.3 Global Biobanking Price by Type (2015-2021)


6.4 Global Biobanking Production Growth by Type (2015-2021)


 


Chapter 7 Global Biobanking Market Analysis by Application


7.1 Global Biobanking Consumption and Market Share by Application (2015-2021)


7.2 Global Biobanking Consumption Growth Rate by Application (2015-2021)


7.3 Market Drivers and Opportunities


7.3.1 Potential Applications


7.3.2 Emerging Markets/Countries


 


Chapter 8 Biobanking Manufacturing Cost Analysis


8.1 Biobanking Key Raw Materials Analysis


8.1.1 Key Raw Materials


8.1.2 Price Trend of Key Raw Materials


8.1.3 Key Suppliers of Raw Materials


8.1.4 Market Concentration Rate of Raw Materials


8.2 Proportion of Manufacturing Cost Structure


8.2.1 Raw Materials


8.2.2 Labour Cost


8.2.3 Manufacturing Expenses


8.3 Manufacturing Process Analysis of Biobanking


 


Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers


9.1 Biobanking Industrial Chain Analysis


9.2 Upstream Raw Materials Sourcing


9.3 Raw Materials Sources of Biobanking Major Manufacturers in 2021


9.4 Downstream Buyers


 


Chapter 10 Marketing Strategy Analysis, Distributors/Traders


10.1 Marketing Channel


10.1.1 Direct Marketing


10.1.2 Indirect Marketing


10.1.3 Marketing Channel Development Trend


10.2 Market Positioning


10.2.1 Pricing Strategy


10.2.2 Brand Strategy


10.2.3 Target Client


10.3 Distributors/Traders List


 


Chapter 11 Market Effect Factors Analysis


11.1 Technology Progress/Risk


11.1.1 Substitutes Threat


11.1.2 Technology Progress in Related Industry


11.2 Consumer Needs/Customer Preference Change


11.3 Economic/Political Environmental Change


 


Chapter 12 Global Biobanking Market Forecast (2021-2027)


12.1 Global Biobanking Production, Revenue Forecast (2021-2027)


12.2 Global Biobanking Production, Consumption Forecast by Regions (2021-2027)


12.3 Global Biobanking Production Forecast by Type (2021-2027)


12.4 Global Biobanking Consumption Forecast by Application (2021-2027)


12.5 Biobanking Price Forecast (2021-2027)


 


Chapter 13 Appendix    


 


 

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

What is Biobanking?

Biobank is a procedure of collecting biological samples and associated information for research and development purposes and is organized systematically. Biobanking is becoming an essential resource in healthcare research for supporting contemporary research, such as personalized medicine and genomics.

What is the market value of Biobanking market?

The Global Biobanking Market Size, Share and Trends are estimated to reach $60,596 million by 2026, growing at a CAGR of 6.3% over the forecast period of 2021-2026.

What are the key factors driving the Biobanking Market?

Biobanking effectively plays a role in advancing translational and biomedical research by preserving and collecting samples, such as nucleic acids and blood tissues that are available for discovering disease-relevant biomarkers. Technological advancements in orthopedic treatments with stem cells are propelling the demand for regenerative medicines across the world.

What are the top companies in the Biobanking Market?

Thermo Fisher Scientific Inc (US), Qiagen N.V. (Germany), Tecan Group Ltd (Switzerland), Brooks Automation (US), Hamilton Company (US), VWR Corporation (US), Worthington Industries (US), Becton, Dickinson and Company (US), LVL Technologies (Germany), Panasonic Healthcare Holdings (Japan)

In which Region the Biobanking market is demanding?

North America held the largest share of the Biobanking market in 2020, with a global market share of 35.3%. The demand for Biobanking in North America is growing owing to the increasing number of research and development activities in genomics, the growing availability of hospital-based biobanks, and the demand for cost-effective drug development.

Which Specimen Type have been included in Biobanking market report?

Blood Products, Cell Lines, Solid Tissue, Nucleic Acid, Biological Fluids, Human Waste Products

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Biobanking Market By Specimen Type (Blood Products...

RD Code : HP22